Measuring central line infection rates in sepsis patients
Part of Infections clinical trials.
This study is about finding how common bloodstream infections are in people with central lines (a special IV for long-term medicines). It will help doctors learn how to prevent these infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with sepsis (a serious infection that affects your whole body).
- You have not received certain antibiotics (non-beta-lactam types) in the last 24 hours.
- Your blood culture sample must not be contaminated with normal skin germs.
- You can be any age or gender.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to reduce infections that can happen when you have a central line, a special tube placed in a large vein to give medicines or fluids. Participating may help improve safety for patients like you.
This study is looking at infections from central lines (special IVs in large veins) in ICU patients across China. It aims to understand how common these infections are and what factors contribute to them.
This study tests a new method to prevent infections from central lines (special IVs placed in large veins) in intensive care units. If you have a central line in place for more than 24 hours, this research may help improve your safety by finding better ways to avoid catheter-related bloodstream infections.
This trial uses machine learning to predict infections that can happen with central lines (special IVs placed in large veins) and aims to reduce how often they occur. It focuses on hospitals with the highest infection rates, so you might be eligible if you receive care at one of these hospitals.
This study uses special genetic testing of bacteria from blood to figure out where central-line bloodstream infections come from. Results may help doctors better identify the source and improve prevention and treatment.
This study tests a new approach to prevent infections on central venous catheters (thin tubes inserted into large veins) in hospital intensive care units. Researchers will study catheters that already show signs of bacterial growth to understand how to better protect patients from catheter-related infections.
Hear when a new Central Line-associated Bloodstream Infection (CLABSI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.